Pheochromocytoma and Paraganglioma (PPGL) research hub
3 indexed studies · 1 currently recruiting
- recruitingPHASE2
An Experimental Study of Belzutifan Impact on Catecholamine Metabolism
This study looks at how a drug called Belzutifan affects chemicals (adrenaline and noradrenaline) in people with a rare growth condition called pheochromocytoma or paraganglioma. We want to see if the drug changes how these chemicals are made and processed in the body over five days.
United Kingdom - active not recruiting
DOTATOC PET/CT for Imaging NET Patients
This study looks at a new type of scan called 68Ga-DOTATOC PET/CT for checking on neuroendocrine tumours (NETs) and similar growths. It compares it to a standard scan to see if it’s better at finding these conditions safely.
Canada - active not recruitingPHASE2
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
This study is looking at a treatment called Lutathera for teenagers aged 12 to 17 with specific types of cancer (GEP-NETs and PPGLs). It aims to see how safe it is and how much medicine goes to the right places in the body.
United States · France · Poland